Pfizer Inc. (pfe) said late Friday it received Food and Drug Administration approval to sell a biotech drug that is similar to Amgen Inc.'s (amgn) Neupogen.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,